CRMD
CorMedix Inc
Price:  
3.35 
USD
Volume:  
508,479.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRMD WACC - Weighted Average Cost of Capital

The WACC of CorMedix Inc (CRMD) is 8.0%.

The Cost of Equity of CorMedix Inc (CRMD) is 9.40%.
The Cost of Debt of CorMedix Inc (CRMD) is 7.00%.

Range Selected
Cost of equity 8.30% - 10.50% 9.40%
Tax rate 3.30% - 10.10% 6.70%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.5% - 8.4% 8.0%
WACC

CRMD WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.83 0.88
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 10.50%
Tax rate 3.30% 10.10%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 7.5% 8.4%
Selected WACC 8.0%